Cancer Research Publishes Matrix-Bio’s Study on Detecting Breast Cancer Recurrence
Posted October 20, 2010 by Matrix-Bio • No Comments
WEST LAFAYETTE, IND., October 20, 2010 – Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain, and ovarian cancer before succumbing to the disease in their early 50s.
“The original diagnosis was devastating, but the panic they felt during follow-up visits was even worse. It was agony to find a recurrence,” explains Krabbe, a retired insurance executive. “For me, it wasn’t ifthe cancer would come back in my sisters, it was when and would there be time to treat it.” Breast cancer recurrence occurs in more than 20 percent of breast cancer survivors.
So the news that a cancer recurrence detection blood test developed by Purdue Research Park-based company Matrix-Bio, Inc. has the potential to detect the recurrence of breast cancer a year in advance of currently available clinical diagnostic tests is something Krabbe applauds.
No comments yet.
Sorry, the comment form is closed at this time.